Future of the Global Blood Plasma Derivatives Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Blood Plasma Derivatives Market Size Growth Forecast: What to Expect by 2025?
The valuation of the blood plasma derivatives market has experienced considerable expansion lately, projected to escalate from $51.81 billion in 2024 to $55.76 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.6%; this upward trajectory during the past period is linked to several factors, including a higher incidence of hemophilia and various bleeding conditions, an aging global populace, heightened levels of disease understanding and detection, an increase in the number of surgical interventions performed, and the expansion of worldwide blood transfusion facilities.

How Will the Blood Plasma Derivatives Market Size Evolve and Grow by 2029?
Anticipation surrounds the blood plasma derivatives market, projecting robust expansion moving forward, with valuations set to reach $79.09 billion by 2029, reflecting a steady compounded annual growth rate of 9.1% throughout this projection window. This upward trajectory is fueled by several key factors: the development of treatments for infrequent medical conditions, the rising prevalence of long-term illnesses, escalating spending across the healthcare sector, a focus on treatments tailored to individual patients, and improvements in medical infrastructure. Significant shifts influencing the market during this period encompass progress in the methods used for plasma separation, a greater emphasis on individualized patient care, the formation of strategic alliances and cooperative ventures, the broadening scope of plasma derivative use within neurology, and ongoing technological leaps in plasma processing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

What Drivers Are Propelling the Growth of Blood Plasma Derivatives Market Forward?
The expanding incidence of conditions compromising the immune system, either partially or entirely, is anticipated to fuel the expansion of the market for blood plasma derivatives, as these derivatives are employed in managing various ailments, prominently including immune deficiency disorders; plasma, being a fluid matrix rich in proteins and salts comprising upwards of a hundred distinct proteins, offers valuable components like immunoglobulins specifically leveraged for tackling primary immunodeficiencies, while inadequate dietary intake or malnutrition resulting in insufficient macro and micronutrients can also precipitate immunodeficiency; to illustrate, data released in March 2022 by Allergy, Asthma & Clinical Immunology pinpointed Common Variable Immunodeficiency (CVID) as the most frequent malady, accounting for 16.6% of cases in the US, 12.9% across international locales, and 13.9% on a global scale, thus underscoring how the rising rate of immune deficiency disorders propels forward the blood plasma derivatives market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

Which Emerging Trends Are Transforming the Blood Plasma Derivatives Market in 2025?
Key players within the blood plasma derivatives sector are prioritizing strategic alliances as a means to enhance their market standing. This collaborative approach ensures a consistent and reliable provision of crucial plasma-derived treatments for patients requiring them, thereby addressing the escalating demand for immunoglobulins both within France and internationally. A notable example occurred in January 2022 when Kedrion S.p.A., an Italian biopharmaceutical firm focused on plasma-derived therapies' creation, manufacturing, and distribution, entered into an agreement with LPB, a pharmaceutical entity based in the UK that focuses on biological medicines. Under this arrangement, Kedrion is set to manufacture immunoglobulins in Hungary utilizing plasma sourced in France by the Etablissement Français du Sang (EFS) and supplied by LFB. These imported quantities originating from LFB in France will serve to augment the existing stock of immunoglobulins slated for distribution to hospitals nationwide, strictly adhering to and overseen by the relevant French health authorities.

What Are the Key Segments in the Blood Plasma Derivatives Market?
The blood plasma derivativesmarket covered in this report is segmented -

1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types
2) By Application: Hemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease; Other Applications
3) By End-User: Hospitals; Clinics; Other End-Users

Subsegments:
1) By Albumin: Human Serum Albumin; Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII; Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX; Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin; Standard Hyperimmune Globulin
6) By Other Types: Fibrinogen; Clotting Factor Concentrates; Plasma-Derived Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Who Are the Key Players Shaping the Blood Plasma Derivatives Market's Competitive Landscape?
Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

What Geographic Markets Are Powering Growth in the Blood Plasma Derivatives Market?
North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.